Wall Street analysts are actively making their voices heard, offering insights and recommendations on various companies. Here’s a roundup of some notable analyst actions that could influence your investment decisions:
*
Abbott Laboratories (ABT):
Oppenheimer analyst Suraj Kalia initiated coverage on Abbott with an ‘Outperform’ rating and a price target of $130. This positive outlook fueled a 0.6% gain in Abbott’s stock price, closing at $113.36 on Monday.*
Arcus Biosciences (RCUS):
Wells Fargo analyst Eva Fortea Verdejo initiated coverage on Arcus Biosciences with an ‘Overweight’ rating and a price target of $29. The news contributed to a 3.9% jump in Arcus Biosciences shares, closing at $17.30 on Monday.*
Howmet Aerospace (HWM):
Susquehanna analyst Charles Minervino initiated coverage on Howmet Aerospace with a ‘Positive’ rating and a price target of $120. This positive sentiment resulted in a 0.8% increase in Howmet Aerospace’s stock price, closing at $102.83 on Monday.*
Bicara Therapeutics (BCAX):
Morgan Stanley analyst Judah Frommer initiated coverage on Bicara Therapeutics with an ‘Overweight’ rating and a price target of $35. Despite the positive rating, Bicara Therapeutics shares experienced a 2.8% decline, closing at $24.45 on Monday.*
First National Corporation (FXNC):
Hovde Group initiated coverage on First National Corporation with an ‘Outperform’ rating and a price target of $22. This bullish outlook led to a 0.9% increase in First National’s stock price, closing at $18.37 on Monday.These analyst ratings provide valuable insights for investors looking to make informed decisions. Remember to conduct thorough research and consider multiple perspectives before making any investment choices.
